E-LIB Suche - Ergebnisse für: Kockx, Mark

1

Automated tumor immunophenotyping predicts clinical benefit..:

Li, Xiao ; Eastham, Jeffrey ; Giltnane, Jennifer M...
The Journal of Pathology. 263 (2024) 2 - p. 190-202 , 2024

Link: https://doi.org/10.1002/..

2

XIAP overexpressing inflammatory breast cancer patients hav..:

Van Berckelaer, Christophe ; Van Laere, Steven ; Lee, Seayoung...
Translational Oncology. 43 (2024) - p. 101907 , 2024

Link: https://doi.org/10.1016/..

3

Publisher Correction: Clinical efficacy and biomarker analy..:

Powles, Thomas ; Kockx, Mark ; Rodriguez-Vida, Alejo...
Nature Medicine. 29 (2023) 12 - p. 3271-3271 , 2023

Link: https://doi.org/10.1038/..

4

Final Results of Neoadjuvant Atezolizumab in Cisplatin-inel..:

Szabados, Bernadett ; Kockx, Mark ; Assaf, Zoe June...
European Urology. 82 (2022) 2 - p. 212-222 , 2022

Link: https://doi.org/10.1016/..

5

A Comprehensive Analysis of Baseline Clinical Characteristi..:

Awada, Gil ; Jansen, Yanina ; Schwarze, Julia Katharina...
Cancers. 13 (2021) 2 - p. 168 , 2021

Link: https://doi.org/10.3390/..

6

In Vitro and In Situ Activity-Based Labeling of Fibroblast ..:

Van Rymenant, Yentl ; Tanc, Muhammet ; Van Elzen, Roos...
Frontiers in Chemistry. 9 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

7

Stromal marker fibroblast activation protein drives outcome..:

Muilwijk, Tim ; Akand, Murat ; Daelemans, Sofie...
PLOS ONE. 16 (2021) 9 - p. e0257195 , 2021

Link: https://doi.org/10.1371/..

8

Vanucizumab mode of action: Serial biomarkers in plasma, tu..:

Heil, Florian ; Babitzki, Galina ; Julien-Laferriere, Alice...
Translational Oncology. 14 (2021) 2 - p. 100984 , 2021

Link: https://doi.org/10.1016/..

9

Intracerebral administration of CTLA-4 and PD-1 immune chec..:

Duerinck, Johnny ; Schwarze, Julia Katharina ; Awada, Gil...
Journal for ImmunoTherapy of Cancer. 9 (2021) 6 - p. e002296 , 2021

Link: https://doi.org/10.1136/..

10

Immune phenotype and histopathological growth pattern in pa..:

Stremitzer, Stefan ; Vermeulen, Peter ; Graver, Shannon...
British Journal of Cancer. 122 (2020) 10 - p. 1518-1524 , 2020

Link: https://doi.org/10.1038/..

11

Absence of BCL-2 Expression Identifies a Subgroup of AML wi..:

haes, Inke De ; Dendooven, Amélie ; Mercier, Marie Le...
Journal of Clinical Medicine. 9 (2020) 10 - p. 3090 , 2020

Link: https://doi.org/10.3390/..

12

A randomized controlled phase II clinical trial on mRNA ele..:

Jansen, Yanina ; Kruse, Vibeke ; Corthals, Jurgen...
Cancer Immunology, Immunotherapy. 69 (2020) 12 - p. 2589-2598 , 2020

Link: https://doi.org/10.1007/..

13

Phase I clinical trial of decitabine (5-aza-2'-deoxycytidin..:

Jansen, Yanina J.L. ; Verset, Gontran ; Schats, Kelly...
ESMO Open. 4 (2019) 2 - p. e000464 , 2019

Link: https://doi.org/10.1136/..

14

Histopathological growth patterns as a candidate biomarker ..:

van Dam, Pieter-Jan ; Daelemans, Sofie ; Ross, Elizabeth...
Seminars in Cancer Biology. 52 (2018) - p. 86-93 , 2018

Link: https://doi.org/10.1016/..

15

PD-L1 Immunohistochemistry Comparability Study in Real-Life..:

Tsao, Ming Sound ; Kerr, Keith M. ; Kockx, Mark...
Journal of Thoracic Oncology. 13 (2018) 9 - p. 1302-1311 , 2018

Link: https://doi.org/10.1016/..